본문 바로가기
KERD
논문KCI 등재

Leptin as a Modulator of Neuroendocrine Function in Humans

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Leptin, a peptide hormone secreted by adipocytes in proportion of the amount of energy stored in fat, plays a central role in regulating human energy homeostasis. In addition, leptin plays a significant permissive role in the physiological regulation of several neuroendocrine axes, including the hypothalamic-pituitary-gonadal, -thyroid, -growth hormone, and -adrenal axes. Decreased levels of leptin, also known as hypoleptinemia, signal to the brain a state of energy deprivation. Hypoleptinemia can be a congenital or acquired condition, and is associated with alterations of the aforementioned axes aimed at promoting survival. More specifically, gonadotropin levels decrease and become less pulsatile under conditions of energy deprivation, and these changes can be at least partially reversed through leptin administration in physiological replacement doses. Similarly, leptin deficiency is associated with thyroid axis abnormalities including abnormal levels of thyrotropin-releasing hormone, and leptin administration may at least partially attenuate this effect. Leptin deficiency results in decreased insulin-like growth factor 1 levels which can be partially ameliorated through leptin administration, and leptin appears to have a much more pronounced effect on the growth of rodents than that of humans. Similarly, adrenal axis function is regulated more tightly by low leptin in rodents than in humans. In addition to congenital leptin deficiency, conditions that may be associated with decreased leptin levels include hypothalamic amenorrhea, anorexia nervosa, and congenital or acquired lipodystrophy syndromes. Accumulating evidence from proof of concept studies suggests that leptin administration, in replacement doses, may ameliorate neuroendocrine abnormalities in individuals who suffer from these conditions.

Abstract

Leptin, a peptide hormone secreted by adipocytes in proportion of the amount of energy stored in fat, plays a central role in regulating human energy homeostasis. In addition, leptin plays a significant permissive role in the physiological regulation of several neuroendocrine axes, including the hypothalamic-pituitary-gonadal, -thyroid, -growth hormone, and -adrenal axes. Decreased levels of leptin, also known as hypoleptinemia, signal to the brain a state of energy deprivation. Hypoleptinemia can be a congenital or acquired condition, and is associated with alterations of the aforementioned axes aimed at promoting survival. More specifically, gonadotropin levels decrease and become less pulsatile under conditions of energy deprivation, and these changes can be at least partially reversed through leptin administration in physiological replacement doses. Similarly, leptin deficiency is associated with thyroid axis abnormalities including abnormal levels of thyrotropin-releasing hormone, and leptin administration may at least partially attenuate this effect. Leptin deficiency results in decreased insulin-like growth factor 1 levels which can be partially ameliorated through leptin administration, and leptin appears to have a much more pronounced effect on the growth of rodents than that of humans. Similarly, adrenal axis function is regulated more tightly by low leptin in rodents than in humans. In addition to congenital leptin deficiency, conditions that may be associated with decreased leptin levels include hypothalamic amenorrhea, anorexia nervosa, and congenital or acquired lipodystrophy syndromes. Accumulating evidence from proof of concept studies suggests that leptin administration, in replacement doses, may ameliorate neuroendocrine abnormalities in individuals who suffer from these conditions.

참고문헌 (101)

  1. Zhang Y, "Positional cloning of the mouse obese gene and its human homologue", Nature, 372, pp.425~432 (1994)
  2. Moschos S, "Leptin and reproduction: a review", Fertil Steril, 77, pp.433~444 (2002)
  3. Blüher S, "Leptin in humans: lessons from translational research", Am J Clin Nutr, 89, pp.991~997 (2009)
  4. Hamnvik OP, "Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study", Metabolism, 60, pp.987~993 (2011)
  5. Matarese G, "Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis", Curr Pharm Des, 13, pp.3676~3680 (2007)
  6. Ahima RS, "Role of leptin in the neuroendocrine response to fasting", Nature, 382, pp.250~252 (1996)
  7. Chan JL, "The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men", J Clin Invest, 111, pp.1409~1421 (2003)
  8. Chan JL, "Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans", Proc Natl Acad Sci U S A, 103, pp.8481~8486 (2006)
  9. Luque RM, "Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob", ob mice, 2007, pp.292, 891~899
  10. Costa A, "Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants", Neuroreport, 8, pp.1131~1134 (1997)
  11. Licinio J, "Human leptin levels are pulsatile and inversely related to pituitary-adrenal function", Nat Med, 3, pp.575~579 (1997)
  12. Boden G, "Effect of fasting on serum leptin in normal human subjects", J Clin Endocrinol Metab, 81, pp.3419~3423 (1996)
  13. Denver RJ, "Evolution of leptin structure and function", Neuroendocrinology, 94, pp.21~38 (2011)
  14. Trayhurn P, "Regulation of leptin production: a dominant role for the sympathetic nervous system?", Proc Nutr Soc, 57, pp.413~419 (1998)
  15. Matarese G, "Leptin in immunology", J Immunol, 174, pp.3137~3142 (2005)
  16. Margetic S, "Leptin: a review of its peripheral actions and interactions", Int J Obes Relat Metab Disord, 26, pp.1407~1433 (2002)
  17. Considine RV, "Serum immunoreactive-leptin concentrations in normal-weight and obese humans", N Engl J Med, 334, pp.292~295 (1996)
  18. Yannakoulia M, "Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans", J Clin Endocrinol Metab, 88, pp.1730~1736 (2003)
  19. Mantzoros CS, "Editorial: leptin as a therapeutic agent--trials and tribulations", J Clin Endocrinol Metab, 85, pp.4000~4002 (2000)
  20. Mantzoros CS, "Role of leptin in reproduction", Ann N Y Acad Sci, 900, pp.174~183 (2000)
  21. Kelesidis T, "Narrative review: the role of leptin in human physiology: emerging clinical applications", Ann Intern Med, 152, pp.93~100 (2010)
  22. Mullington JM, "Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men", J Neuroendocrinol, 15, pp.851~854 (2003)
  23. Scheer FA, "Adverse metabolic and cardiovascular consequences of circadian misalignment", Proc Natl Acad Sci U S A, 106, pp.4453~4458 (2009)
  24. Mantzoros CS, "Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men", Obes Res, 6, pp.179~186 (1998)
  25. Chen H, "Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db", db mice, 1996, pp.84, 491~495
  26. Clément K, "A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction", Nature, 392, pp.398~401 (1998)
  27. Mantzoros CS, "Leptin: in search of role(s) in human physiology and pathophysiology", Clin Endocrinol (Oxf), 49, pp.551~567 (1998)
  28. Tartaglia LA, "Identification and expression cloning of a leptin receptor, OB-R", Cell, 83, pp.1263~1271 (1995)
  29. Fei H, "Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues", Proc Natl Acad Sci U S A, 94, pp.7001~7005 (1997)
  30. Baumann H, "The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors", Proc Natl Acad Sci U S A, 93, pp.8374~8378 (1996)
  31. Maffei M, "Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus", Proc Natl Acad Sci U S A, 92, pp.6957~6960 (1995)
  32. Papathanassoglou E, "Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice", J Immunol, 176, pp.7745~7752 (2006)
  33. Moon HS, "Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans", Diabetes Care, 34, pp.132~138 (2011)
  34. Moon HS, "Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance", Diabetes, 60, pp.1647~1656 (2011)
  35. Cioffi JA, "Novel B219", OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction, 1996, pp.2, 585~589
  36. Lee GH, "Abnormal splicing of the leptin receptor in diabetic mice", Nature, 379, pp.632~635 (1996)
  37. Peelman F, "Techniques: new pharmacological perspectives for the leptin receptor", Trends Pharmacol Sci, 27, pp.218~225 (2006)
  38. Sun Q, "Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels", Hum Mol Genet, 19, pp.1846~1855 (2010)
  39. Sinha MK, "Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects", J Clin Invest, 97, pp.1344~1347 (1996)
  40. Shea SA, "Independent circadian and sleep", wake regulation of adipokines and glucose in humans, 2005, pp.90, 2537~2544
  41. Rosenbaum M, "Effects of gender, body composition, and menopause on plasma concentrations of leptin", J Clin Endocrinol Metab, 81, pp.3424~3427 (1996)
  42. Saad MF, "Sexual dimorphism in plasma leptin concentration", J Clin Endocrinol Metab, 82, pp.579~584 (1997)
  43. Roemmich JN, "Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids", Am J Physiol, 275(3 Pt 1), pp.543~551 (1998)
  44. Lin KC., "Increase of leptin levels following exogenous administration of estrogen in women with normal menstruation", Kaohsiung J Med Sci, 16, pp.13~19 (2000)
  45. Shimizu H, "Estrogen increases in vivo leptin production in rats and human subjects", J Endocrinol, 154, pp.285~292 (1997)
  46. Asimakopoulos B, "Serum pattern of circulating adipokines throughout the physiological menstrual cycle", Endocr J, 56, pp.425~433 (2009)
  47. Montague CT, "Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution", Diabetes, 46, pp.342~347 (1997)
  48. Farooqi IS, "Effects of recombinant leptin therapy in a child with congenital leptin deficiency", N Engl J Med, 341, pp.879~884 (1999)
  49. Farooqi IS, "Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine", metabolic dysfunction of human congenital leptin deficiency, 2002, pp.110, 1093~1103
  50. Paz-Filho G, "Congenital leptin deficiency and thyroid function", Thyroid Res, 2, pp.11~ (2009)
  51. Rosenbaum M, "Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight", J Clin Invest, 115, pp.3579~3586 (2005)
  52. Chan JL, "Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans", Clin Endocrinol (Oxf), 66, pp.49~57 (2007)
  53. Mantzoros C, "Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain", J Clin Endocrinol Metab, 82, pp.1845~1851 (1997)
  54. Welt CK, "Recombinant human leptin in women with hypothalamic amenorrhea", N Engl J Med, 351, pp.987~997 (2004)
  55. Strobel A, "A leptin missense mutation associated with hypogonadism and morbid obesity", Nat Genet, 18, pp.213~215 (1998)
  56. Licinio J, "Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults", Proc Natl Acad Sci U S A, 101, pp.4531~4536 (2004)
  57. Mantzoros CS, "A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty", J Clin Endocrinol Metab, 82, pp.1066~1070 (1997)
  58. Ahima RS, "Leptin accelerates the onset of puberty in normal female mice", J Clin Invest, 99, pp.391~395 (1997)
  59. Chen R, "Effect of central antileptin antibody on the onset of female rat puberty", Int J Pediatr Endocrinol, 2009, pp.194807~ (2009)
  60. Chehab FF, "Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin", Nat Genet, 12, pp.318~320 (1996)
  61. Yu WH, "Role of leptin in hypothalamic-pituitary function", Proc Natl Acad Sci U S A, 94, pp.1023~1028 (1997)
  62. Chan JL, "Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity", Clin Pharmacokinet, 47, pp.753~764 (2008)
  63. Quennell JH, "Leptin indirectly regulates gonadotropin-releasing hormone neuronal function", Endocrinology, 150, pp.2805~2812 (2009)
  64. Hill JW, "Hypothalamic pathways linking energy balance and reproduction", Am J Physiol Endocrinol Metab, 294, pp.827~832 (2008)
  65. Dardeno TA, "Leptin in human physiology and therapeutics", Front Neuroendocrinol, 31, pp.377~393 (2010)
  66. Lehman MN, "Minireview: kisspeptin", neurokinin B, Endocrinology, pp.2010, 151[DOI]
  67. Smith JT, "KiSS-1 neurones are direct targets for leptin in the ob", ob mouse, 2006, pp.18, 298~303
  68. Kotani M, "The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54", J Biol Chem, 276, pp.34631~34636 (2001)
  69. Matsuzaki T, "Fasting reduces the kiss1 mRNA levels in the caudal hypothalamus of gonadally intact adult female rats", Endocr J, 58, pp.1003~1012 (2011)
  70. Castellano JM, "Early metabolic programming of puberty onset: impact of changes in postnatal feeding and rearing conditions on the timing of puberty and development of the hypothalamic kisspeptin system", Endocrinology, 152, pp.3396~3408 (2011)
  71. Irwig MS, "Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat", Neuroendocrinology, 80, pp.264~272 (2004)
  72. Gottsch ML, "A role for kisspeptins in the regulation of gonadotropin secretion in the mouse", Endocrinology, 145, pp.4073~4077 (2004)
  73. Thompson EL, "Central and peripheral administration of kisspeptin- 10 stimulates the hypothalamic-pituitary-gonadal axis", J Neuroendocrinol, 16, pp.850~858 (2004)
  74. Louis GW, "Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis", Endocrinology, 152, pp.2302~2310 (2011)
  75. Donato J Jr, "Leptin’s effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons", J Clin Invest, 121, pp.355~368 (2011)
  76. Mantzoros CS, "Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans", J Clin Endocrinol Metab, 86, pp.3284~3291 (2001)
  77. van der Kroon PH, "Congenital hypothyroidism in latent obese (ob", ob) mice, 1982, pp.6, 83~90
  78. Légrádi G, "Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus", Endocrinology, 138, pp.2569~2576 (1997)
  79. Kim MS, "The central melanocortin system affects the hypothalamo- pituitary thyroid axis and may mediate the effect of leptin", J Clin Invest, 105, pp.1005~1011 (2000)
  80. Sanchez VC, "Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone", J Clin Invest, 114, pp.357~369 (2004)
  81. 김상용, "Leptin in human physiology and pathophysiology", AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 301(4), pp.567~584, AMER PHYSIOLOGICAL SOC
  82. Shetty GK, "Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet", Eur J Endocrinol, 165, pp.249~254 (2011)
  83. Farooqi IS, "Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor", N Engl J Med, 356, pp.237~247 (2007)
  84. Chan JL, "Leptin does not mediate short-term fasting-induced changes in growth hormone pulsatility but increases IGF-I in leptin deficiency states", J Clin Endocrinol Metab, 93, pp.2819~2827 (2008)
  85. Pralong FP, "Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland", Endocrinology, 139, pp.4264~4268 (1998)
  86. Heiman ML, "Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress", Endocrinology, 138, pp.3859~3863 (1997)
  87. Sienkiewicz E, "Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women", Metabolism, 60, pp.1211~1221 (2011)
  88. Blüher S, "Leptin deficiency: clinical implications and opportunities for therapeutic interventions", J Investig Med, 57, pp.784~788 (2009)
  89. Montague CT, "Congenital leptin deficiency is associated with severe early-onset obesity in humans", Nature, 387, pp.903~908 (1997)
  90. Chan JL, "Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa", Lancet, 366, pp.74~85 (2005)
  91. Miller KK, "Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake", J Clin Endocrinol Metab, 83, pp.2309~2312 (1998)
  92. Chou SH, "Leptin is an effective treatment for hypothalamic amenorrhea", Proc Natl Acad Sci U S A, 108, pp.6585~6590 (2011)
  93. Arimura C, "Predictors of menstrual resumption by patients with anorexia nervosa", Eat Weight Disord, 15, pp.226~233 (2010)
  94. Fiorenza CG, "Lipodystrophy: pathophysiology and advances in treatment", Nat Rev Endocrinol, 7, pp.137~150 (2011)
  95. Pardini VC, "Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes", J Clin Endocrinol Metab, 83, pp.503~508 (1998)
  96. Nagy GS, "Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin", Clin Infect Dis, 36, pp.795~802 (2003)
  97. Musso C, "The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients", Metabolism, 54, pp.255~263 (2005)
  98. Oral EA, "Leptin-replacement therapy for lipodystrophy", N Engl J Med, 34, pp.570~578 (2002)
  99. Chong AY, "Efficacy of leptin therapy in the different forms of human lipodystrophy", Diabetologia, 53, pp.27~35 (2010)
  100. Mantzoros CS, "W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?", Endocr Pract, pp.1~18 (2010)
  101. Mantzoros CS., "Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?", J Clin Endocrinol Metab, 94, pp.1089~1091 (2009)

관련 논문AI추천

이 간행물의 다른 논문 (15건)